Analysts: Aegerion Pharmaceuticals Inc (AEGR.O)

AEGR.O on Nasdaq

27.89USD
12:57pm EDT
Price Change (% chg)

$-0.82 (-2.85%)
Prev Close
$28.71
Open
$28.40
Day's High
$29.10
Day's Low
$27.55
Volume
593,261
Avg. Vol
1,043,943
52-wk High
$101.00
52-wk Low
$27.55

Search Stocks

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.14 December 11 Jul 2014

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 6 7 7 7
(2) OUTPERFORM 2 2 2 3
(3) HOLD 1 1 1 0
(4) UNDERPERFORM 1 1 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.70 1.64 1.40 1.30

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-14 10 48.94 52.20 42.00 43.73
Quarter Ending Dec-14 10 61.74 71.30 51.00 53.97
Year Ending Dec-14 10 173.07 185.00 153.00 143.68
Year Ending Dec-15 9 306.08 382.96 240.00 264.86
Earnings (per share)
Quarter Ending Sep-14 10 -0.14 -0.01 -0.33 0.58
Quarter Ending Dec-14 10 0.10 0.29 -0.21 0.88
Year Ending Dec-14 10 -0.94 -0.48 -1.52 0.60
Year Ending Dec-15 9 2.16 3.72 1.00 4.13

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-14 33.58 26.97 6.60 19.67
Quarter Ending Dec-13 24.51 24.50 0.01 0.06
Quarter Ending Sep-13 13.07 16.33 3.26 24.91
Quarter Ending Jun-13 4.27 6.49 2.22 52.10
Quarter Ending Mar-13 0.63 1.23 0.60 95.52
Earnings (per share)
Quarter Ending Mar-14 -0.35 -0.54 0.19 -54.77
Quarter Ending Dec-13 -0.30 -0.47 0.17 -59.00
Quarter Ending Sep-13 -0.50 -0.43 0.07 -14.43
Quarter Ending Jun-13 -0.62 -0.66 0.04 -6.64
Quarter Ending Mar-13 -0.74 -0.64 0.10 -13.13

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-14 48.94 48.94 49.43 49.27 43.73
Quarter Ending Dec-14 61.74 61.74 62.30 62.42 53.97
Year Ending Dec-14 173.07 173.07 175.40 175.77 143.68
Year Ending Dec-15 306.08 306.08 310.94 312.72 264.86
Earnings (per share)
Quarter Ending Sep-14 -0.14 -0.14 -0.13 -0.14 0.58
Quarter Ending Dec-14 0.10 0.10 0.10 0.08 0.88
Year Ending Dec-14 -0.94 -0.94 -0.90 -0.95 0.60
Year Ending Dec-15 2.16 2.16 2.31 2.36 4.13

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-14 0 0 0 0
Quarter Ending Dec-14 0 0 0 0
Year Ending Dec-14 0 0 0 0
Year Ending Dec-15 0 0 0 0
Earnings
Quarter Ending Sep-14 0 0 0 0
Quarter Ending Dec-14 0 0 0 0
Year Ending Dec-14 0 0 0 0
Year Ending Dec-15 0 0 0 0

Analyst Research Reports

Report Title Price
Provider: New Constructs, LLC
$25.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: Wright Reports
$75.00
Provider: Pechala's Reports
$15.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks